UBS Downgrades Surgery Partners to Neutral From Buy, Sets $23.50 Price Target
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Nasdaq pauses volatility trading
Nasdaq announced a volatility trading pause at 11:22 a.m.
L impact | EQUITY | Oct 29, 2026, 03:27 PM UTC
DFM Reports Quarterly Net Profit of 130.5 Million Dirhams
M impact | EQUITY | Oct 29, 2026, 03:21 PM UTC
Oshkosh Reports Third-Quarter Revenue of $2.84 Billion
Oshkosh reported third-quarter 2026 revenue of $2.84 billion, up 5.7% year over year. Net income fell 29.5% to $138.4 million and diluted EPS declined 27% to $2.22.
M impact | EQUITY | Oct 29, 2026, 03:21 PM UTC
Pitney Bowes Reports Quarterly Revenue of $456.18 Million, Net Income of $52.67 Million
Pitney Bowes reported quarterly revenue of $456.18 million and net income of $52.67 million, compared with $459.68 million and $51.96 million a year earlier. Diluted EPS was $0.37,
M impact | EQUITY | Oct 29, 2026, 03:21 PM UTC
Bristol Myers Squibb Reports Q3 2026 Revenue of $13.07B, EPS of $1.05
Revenue rose 6.9% year over year to $13.07 billion. Net income fell 1.5% to $2.16 billion, while diluted EPS declined 2.8% to $1.05.
M impact | EQUITY | Oct 29, 2026, 03:21 PM UTC
DFM quarterly net profit attributable at 130.5 million dirhams
M impact | EQUITY | Oct 29, 2026, 03:21 PM UTC